Indore Online Journal

Delveinsight Business Research LLP

DelveInsight’s “Hypoxic Ischemic Encephalopathy Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Hypoxic Ischemic Encephalopathy Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Hypoxic Ischemic Encephalopathy market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Hypoxic Ischemic Encephalopathy: An Overview

Hypoxic-ischemic encephalopathy (HIE) is a serious and life-threatening type of newborn brain damage (brain dysfunction) that occurs when the brain doesn’t receive enough oxygen and blood flow for a period of time. As the name suggests, Hypoxic means, not enough oxygen, ischemic means not enough blood flow, and encephalopathy mean brain disorder.

It is vital to note that there is currently no approved treatment option for Hypoxic Ischemic Encephalopathy. HIE is mainly managed using therapeutic hypothermia treatment, where the baby’s brain or body is cooled below normal temperatures to slow the cascade effect that causes widespread damage.

Hypoxic Ischemic Encephalopathy Market Key Facts

• As per the HIE Help Center, Neonatal HIE is estimated to occur in about 1.5 per 1,000 live births. Among infants with moderate HIE, 10-20% develop minor neurological conditions, and 30-50% develop more serious complications.

• In a population-based study from January 2010 to December 2017 by Hage et al. (2021), 5201 babies with a diagnosis of HIE received TH or died; annual numbers increased over the study period. It was concluded that treatment with TH for HIE has increased in England, Scotland and Wales. An increasing proportion of treated infants have a mild HIE diagnosis or less severe clinical hypoxia markers.

• Neonatal encephalopathy due to birth asphyxia and trauma is the second leading cause of death in the first month of a child’s life. Close to half a million newborns died due to this condition in 2017. 
  

Hypoxic Ischemic Encephalopathy Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Hypoxic Ischemic Encephalopathy market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Hypoxic Ischemic Encephalopathy market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Hypoxic Ischemic Encephalopathy Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Hypoxic Ischemic Encephalopathy Epidemiology Segmentation

• Total incident Cases of Hypoxic Ischemic Encephalopathy 

• Total incident cases of Hypoxic Ischemic Encephalopathy segmented by severity

• Total treated cases of Hypoxic Ischemic Encephalopathy

Hypoxic Ischemic Encephalopathy Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hypoxic Ischemic Encephalopathy market or expected to get launched during the study period. The analysis covers Hypoxic Ischemic Encephalopathy market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Hypoxic Ischemic Encephalopathy Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/hypoxic-ischemic-encephalopathy-market

Hypoxic Ischemic Encephalopathy Therapeutics Analysis

The dynamics of the Hypoxic Ischemic Encephalopathy (HIE) market are expected to improve in the coming years due to the increase in R&D activities and the introduction of new medicines.

Some of the key companies in the Hypoxic Ischemic Encephalopathy Market include:

• Chiesi

• ReAlta Life Sciences

• Hope Biosciences

• GW Pharmaceuticals

And others

Hypoxic Ischemic Encephalopathy Therapies covered in the report include:

• PIC1-dPEG24 (RLS-0071)

• HB-adMSC

• Intravenous CBD formulation

And many more

Get More Detailed Insights Into the Emerging Therapies & Key Companies –   https://www.delveinsight.com/sample-request/hypoxic-ischemic-encephalopathy-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Hypoxic Ischemic Encephalopathy Competitive Intelligence Analysis

4. Hypoxic Ischemic Encephalopathy Market Overview at a Glance

5. Hypoxic Ischemic Encephalopathy Disease Background and Overview

6. Hypoxic Ischemic Encephalopathy Patient Journey

7. Hypoxic Ischemic Encephalopathy Epidemiology and Patient Population

8. Hypoxic Ischemic Encephalopathy Treatment Algorithm, Current Treatment, and Medical Practices

9. Hypoxic Ischemic Encephalopathy Unmet Needs

10. Key Endpoints of Hypoxic Ischemic Encephalopathy Treatment

11. Hypoxic Ischemic Encephalopathy Marketed Products

12. Hypoxic Ischemic Encephalopathy Emerging Therapies

13. Hypoxic Ischemic Encephalopathy Seven Major Market Analysis

14. Attribute Analysis

15. Hypoxic Ischemic Encephalopathy Market Outlook (7 major markets)

16. Hypoxic Ischemic Encephalopathy Access and Reimbursement Overview

17. KOL Views on the Hypoxic Ischemic Encephalopathy Market.

18. Hypoxic Ischemic Encephalopathy Market Drivers

19. Hypoxic Ischemic Encephalopathy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/hypoxic-ischemic-encephalopathy-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Other Trending Reports by DelveInsight

Total Knee Arthroplasty Market
“Total Knee Arthroplasty Market” research report provides comprehensive insights into the historic and forecasted market size, share, trends, and growth estimation for Total Knee Arthroplasty. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global Total Knee Arthroplasty market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/